LLY
924.69
+0.17%↑
UNH
589.75
-0.76%↓
NVO
137
+0.02%↑
JNJ
167.01
+0.91%↑
ABBV
195.83
+0.9%↑
LLY
924.69
+0.17%↑
UNH
589.75
-0.76%↓
NVO
137
+0.02%↑
JNJ
167.01
+0.91%↑
ABBV
195.83
+0.9%↑
LLY
924.69
+0.17%↑
UNH
589.75
-0.76%↓
NVO
137
+0.02%↑
JNJ
167.01
+0.91%↑
ABBV
195.83
+0.9%↑
LLY
924.69
+0.17%↑
UNH
589.75
-0.76%↓
NVO
137
+0.02%↑
JNJ
167.01
+0.91%↑
ABBV
195.83
+0.9%↑
LLY
924.69
+0.17%↑
UNH
589.75
-0.76%↓
NVO
137
+0.02%↑
JNJ
167.01
+0.91%↑
ABBV
195.83
+0.9%↑
Overview
Share price change
24h
Current
Min
0.35
Max
0.37
Next Earnings | 7 lis 2024 |
---|
Aptose Biosciences Inc Chart
Past performance is not a reliable indicator of future results.
Related News
16 wrz 2024, 23:40 UTC
Stocks to Watch: Intel, Netcapital, Microsoft
DJ
Read
16 wrz 2024, 22:56 UTC
Xero Bolsters Customer Insights With $70 Million Acquisition of Syft
DJ
Read
16 wrz 2024, 19:21 UTC
Vista Equity Partners, Blackstone Close to $8 Billion Buyout Deal for Smartsheet, Reuters Reports
DJ
Read
16 wrz 2024, 22:47 UTC
Auckland International Airport's August Traffic Underwhelms -- Market Talk
DJ
Read
16 wrz 2024, 22:47 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Read
16 wrz 2024, 22:47 UTC
Global Equities Roundup: Market Talk
DJ
Read
16 wrz 2024, 22:41 UTC
Xero Bolsters Customer Insights With $70 Mln Acquisition of Syft
DJ
Read
16 wrz 2024, 22:37 UTC
Santos to Own 36.5% of Bayu-Undan Following Sale, Purchase Deed
DJ
Read
16 wrz 2024, 22:36 UTC
Santos: Production Sharing Contract for Bayu-Undan to Cease at End-June 2026 or When Output Stops if Earlier
DJ
Read
16 wrz 2024, 22:35 UTC
Santos: Bayu-Undan JV Executes Sale, Purchase Deed to Transfer 16% Stake in Upstream Project to Timor GAP
DJ
Read
16 wrz 2024, 22:34 UTC
Xero: Syft's More Than 70 Employees Will Transition With Acquisition
DJ
Read
16 wrz 2024, 22:31 UTC
Xero: Syft Will Still Be Available as a Standalone Offering
DJ
Read
16 wrz 2024, 22:30 UTC
Xero: Syft Is Used in More Than 80 Countries
DJ
Read
16 wrz 2024, 22:30 UTC
Xero Expects to Complete Acquisition of Johannesburg-Based Syft in 3Q FY25
DJ
Read
16 wrz 2024, 22:29 UTC
Xero to Pay Balance in Earnouts, Restricted Stock Over Three Years
DJ
Read
16 wrz 2024, 22:28 UTC
Xero Will Pay US$40 Mln Up Front Including US$10 Mln in Shares
DJ
Read
16 wrz 2024, 22:28 UTC
Xero Will Embed Syft to Accelerate Insights, Analytics Offerings
DJ
Read
16 wrz 2024, 22:27 UTC
Xero: Syft Services Accountants, Bookkeepers, Small Businesses
DJ
Read
16 wrz 2024, 22:27 UTC
Auckland Airport Raises More Equity Than Citi Expected -- Market Talk
DJ
Read
16 wrz 2024, 22:26 UTC
Xero: Syft Is a Cloud-Based Reporting, Insights, Analytics Platform
DJ
Read
16 wrz 2024, 22:26 UTC
Xero Acquiring Syft Analytics for Up to US$70 Million
DJ
Read
16 wrz 2024, 22:08 UTC
Microsoft Boosts Dividend, Authorizes Up to $60B of Buybacks
DJ
Read
16 wrz 2024, 21:17 UTC
Intel CEO Lays Out New Steps to Cut Costs and Bolster Chip-Making Division -- 2nd Update
DJ
Read
16 wrz 2024, 21:16 UTC
Tech Growth Is Slowing. These 6 Companies Could Still Shine. -- Barrons.com
DJ
Read
16 wrz 2024, 20:50 UTC
Financial Services Roundup: Market Talk
DJ
Read
16 wrz 2024, 20:46 UTC
Amazon Tells Workers to Return to Office Five Days a Week -- 2nd Update
DJ
Read
16 wrz 2024, 20:34 UTC
Intel CEO Lays Out New Steps to Cut Costs and Bolster Chip-Making Division -- Update
DJ
Read
16 wrz 2024, 20:28 UTC
Boeing Freezes Hiring, Delays Pay Raises as Strike Worsens Finances -- 2nd Update
DJ
Read
16 wrz 2024, 20:19 UTC
Dow Hits Record as Investors Bet on Bigger Fed Cut -- WSJ
DJ
Read
16 wrz 2024, 20:07 UTC
Intel CEO Lays Out New Steps to Cut Costs and Bolster Chip-Making Division -- WSJ
DJ
Read
Peer Comparison
Price change
Aptose Biosciences Inc Forecast
Rating Consensus
By TipRanks
0 ratings
0
Buy
0
Hold
0
Sell
Based on 0 analysts giving stock ratings to Aptose Biosciences Inc - Dist in the past 3 months.